Hypermarcas (OTCMKTS:HYPMY) Shares Down 6% – Here’s What Happened

Hypermarcas (OTCMKTS:HYPMY) shares fell 6% during mid-day trading on Monday . The company traded as low as $3.75 and last traded at $3.75. 2,014 shares traded hands during trading, a decline of 91% from the average daily volume of 23,060 shares. The stock had previously closed at $3.99.

Wall Street Analysts Forecast Growth

HYPMY has been the subject of a number of recent analyst reports. Jefferies Financial Group raised Hypermarcas to a “strong-buy” rating in a report on Monday, July 20th. Zacks Research raised shares of Hypermarcas to a “hold” rating in a report on Wednesday, April 29th. One investment analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Buy”.

Hypermarcas Price Performance

The company has a 50 day moving average of $4.15 and a 200-day moving average of $4.38. The company has a market cap of $2.84 billion, a P/E ratio of 8.41 and a beta of 0.71.

Hypermarcas (OTCMKTS:HYPMY) last announced its earnings results on Wednesday, April 29th. The company reported $0.10 earnings per share for the quarter. Hypermarcas had a return on equity of 14.08% and a net margin of 19.41%.The business had revenue of $383.13 million for the quarter. Research analysts anticipate that Hypermarcas will post 0.53 EPS for the current year.

Hypermarcas Company Profile

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.